1. Home
  2. |Insights
  3. |Orange County Business Journal Honors Chahira Solh at Women in Business Awards

Orange County Business Journal Honors Chahira Solh at Women in Business Awards

Firm News | 1 min read | 11.11.24

Orange County – November 11, 2024: The Orange County Business Journal honored Crowell & Moring’s Chahira Solh and other women business leaders from across Orange County at the publication’s 30th annual Women in Business Awards ceremony on Oct. 30, 2024.  

Solh is a partner in Crowell’s Orange County office and serves as chair of the firm’s executive committee and as a member of the management board.

In its special report, OCBJ described Solh as “a trailblazer and pioneering leader, whose innovative and strategic vision have elevated Crowell to remarkable heights.”

Solh is a trusted advisor on antitrust issues for a number of the country’s most recognizable companies, including in the auto, aviation, health care, and defense industries. Her practice focuses on all aspects of antitrust law, including litigation and government enforcement actions, joint venture analysis, merger control, and affirmative recovery opportunities.

To read more about the nominees for the 2024 Women in Business Awards, visit here.

About Crowell & Moring LLP

Crowell & Moring is an international law firm with operations in the United States, Europe, MENA, and Asia. Drawing on significant government, business, industry and legal experience, the firm helps clients capitalize on opportunities and provides creative solutions to complex litigation and arbitration, regulatory and policy, and corporate and transactional issues. The firm is consistently recognized for its commitment to pro bono service as well as its programs and initiatives to advance diversity, equity, and inclusion.  

Media Contact:
Email: prteam@crowell.com

Insights

Firm News | 1 min read | 11.08.24

Crowell & Moring Represents Marshall Wace as Lead Investor in Inquis Medical’s $40 Million Series B Financing

San Francisco – November 8, 2024:  Marshall Wace led Inquis Medical’s oversubscribed $40 million Series B round, along with participation from existing investors, including ShangBay Capital, Yu Star, EnPointe Ventures, and Pierre Lamond.